Bevacizumab/povidone-iodineVarious complications: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1577卷 / 1期

关键词：

D O I：

10.1007/s40278-015-10478-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：65 / 65

相关论文

共 50 条

[31] Multiple drugsInfectious complications and lack of efficacy: 7 case reports
[J]. Reactions Weekly, 2021, 1879 (1) : 257 - 257
[32] Bevacizumab/erlotinibSkin and subcutaneous tissue disorders, malaise and hypertension: 7 case reports
[J]. Reactions Weekly, 2018, 1733 (1) : 84 - 84
[33] Povidone-iodineContact dermatitis: 27 case reports
[J]. Reactions Weekly, 2016, 1602 (1) : 207 - 207
[34] Bevacizumab/triamcinoloneEndophthalmitis: 14 case reports
[J]. Reactions Weekly, 2023, 1960 (1) : 105 - 105
[35] Bevacizumab/paclitaxelDysphonia: 4 case reports
[J]. Reactions Weekly, 2014, 1518 (1) : 47 - 47
[36] Bevacizumab/ranibizumabEndophthalmitis: 5 case reports
[J]. Reactions Weekly, 2015, 1547 (1) : 60 - 60
[37] Bevacizumab/corticosteroidsOsteonecrosis: 3 case reports
[J]. Reactions Weekly, 2013, 1444 (1) : 11 - 11
[38] Bevacizumab/ranibizumabEndophthalmitis: 3 case reports
[J]. Reactions Weekly, 2015, 1576 (1) : 61 - 61
[39] Bevacizumab/ranibizumabEndophthalmitis: 16 case reports
[J]. Reactions Weekly, 2016, 1592 (1) : 49 - 49
[40] Bevacizumab/dexamethasoneEndophthalmitis: 5 case reports
[J]. Reactions Weekly, 2017, 1653 (1) : 73 - 73

← 1 2 3 4 5 →